Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria
收藏Mendeley Data2026-04-09 收录
官方服务:
资源简介:
Supplementary material for article published in Clinical Experimental Allergy (Baumann et al): Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria




